The OCTAVE (Oral Clinical Trials for tofAcitinib in ulceratiVE colitis) global clinical program for oral tofacitinib includes three Phase 3 studies and a long-term extension study. OCTAVE ...

Reference Rubin DT, et al; Extraintestinal manifestations at baseline, and effect of tofacitinib in patients with moderate to severe ulcerative colitis in the OCTAVE program.

Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in ulcerative colitis program at the 11th Congress of European Crohn's and ...